News

Dr Caggiano will continue to manage the preclinical and R&D departments, as well as oversee Acorda’s preclinical programs that aim to develop novel approaches to the treatment of

The series B financing included participation from all of Marinus’s existing investors, including Canaan Partners, Domain Associates, Sofinnova Ventures and Foundation Medical Partners. The funding will advance the

Medtronic has also recently acquired Ventor Technologies, a developer of percutaneous, catheter-based transapical aortic valve replacement products. Bill Hawkins, chairman and CEO of Medtronic, said: “These acquisitions position

Lanthanum carbonate tablets are used in cases of kidney failure and would facilitate phosphate absorption. Lanthanum carbonate tablets are sold under the brand name of Fosrenol by the

Existing investors Domain Associates, Latterell Venture Partners, Novo, Mitsui Ventures, Royal Bank of Canada and The Vertical Group also participated in the financing. Tim Harkness, president and CEO

Most recently, Dr Newbold was senior vice president of business development at Celldex Therapeutics. Dr Newbold holds an MBA from Columbia University and received his PhD in organic

Mr Terry is the co-founder and former director at Genomic Health, a personalized medicine company. He is also a founder of the Personalized Medicine Coalition, and co-founder and

The funding will be applied to the company’s DM-99 development program for the treatment of type 2 diabetes. Reggie Bowerman, president and CEO of DiaMedica, said: “We are

The new drug application (NDA) is supported by positive data from completed pivotal studies in which ondansetron orally dissolving film strip (ODFS) demonstrated bioequivalence against GlaxoSmithKline’s Zofran ODT